Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Preferred Stock Liabilities (2025 - 2026)

Updated

Valion Bio's Preferred Stock Liabilities came in at $6.22 million for Q2 2026, compared with $374,000 a year earlier.

Analysis

Valion Bio (VBIO) Preferred Stock Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Valion Bio's Preferred Stock Liabilities was $6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Valion Bio 129,792.00 -19.31 Mn - 6.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.22 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 2.18 Mn
Jun 30, 2025 374,000.00
API Access

Valion Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=VBIO&period=max&api_key=YOUR_API_KEY